Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Novo Nordisk to Withdraw All Forms of Levemir in the UK by End‑2026 – DHSC Issues National Patient Safety Alert Mandating Insulin Switches
CompanyDrug

Novo Nordisk to Withdraw All Forms of Levemir in the UK by End‑2026 – DHSC Issues National Patient Safety Alert Mandating Insulin Switches

According to a notice from the UK Department of Health and Social Care (DHSC), Novo Nordisk A/S (NYSE: NVO) will withdraw all forms of Levemir (insulin detemir) by the end…

Chai Discovery Announces Collaboration with GSK – AI Protein Folding and Design Platform to Power Drug Discovery Across GSK's Pipeline

Chai Discovery Announces Collaboration with GSK – AI Protein Folding and Design Platform to Power Drug Discovery Across GSK’s Pipeline

GeneScience Pharmaceuticals' 6‑Month Long‑Acting Leuprolide Mesylate Injection Approved in China – First Half‑Year Dosing GnRHa for Prostate Cancer ADT

GeneScience Pharmaceuticals’ 6‑Month Long‑Acting Leuprolide Mesylate Injection Approved in China – First Half‑Year Dosing GnRHa for Prostate Cancer ADT

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Ascentage Pharma’s Lisaftoclax (APG-2575) Gets FDA Green Light for Phase III Study

CompanyMedical Device

Venus Medtech Receives FDA IDE Approval for VenusP-Valve, a Milestone for Chinese Heart Valve Technology

CompanyMedical Device

DaVinci Single Port System Launches in Hainan with Successful Surgeries

CompanyDrug

Abbisko Therapeutics Initiates Phase II Clinical Trial for Pimicotinib in Tendon Sheath Giant Cell Tumor

CompanyMedical Device

Peijia Medical Commences Clinical Study for Taurus Trio TAVR System with First Patient Enrollment

CompanyDrug

RemeGen’s Novel Bispecific Antibody RC148 Receives Clinical Trial Approval

CompanyDrug

Everest Medicines Completes Enrollment for Nefecon’s Phase III Extension Study in China

CompanyDrug

Transcenta Holdings Gets CDE Approval for Phase II Study of TST002 for Bone Density

Show More